Cargando…
Sclerodermatous Graft-Versus-Host Disease: A Rare Sequela of Hematopoietic Stem Cell Transplantation
Although graft-versus-host disease (GVHD) is a common immunologic reaction after an allogeneic hematopoietic stem cell transplant (HSCT), progression into sclerodermatous GVHD is a rare sequela. It can present locally or generalized with various cutaneous and mucocutaneous manifestations, resulting...
Autores principales: | Jabin, Mohamad, Batta, Sonali, Mian, Madeeha, Parekh, Palak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685686/ https://www.ncbi.nlm.nih.gov/pubmed/38034201 http://dx.doi.org/10.7759/cureus.47963 |
Ejemplares similares
-
PReS-FINAL-2127: Sclerodermatous graft versus host disease
por: Stevenson, JR, et al.
Publicado: (2013) -
Calcinosis Cutis Related to Sclerodermatous Chronic Graft Versus Host Disease
por: Lipshutz, Gabriel H., et al.
Publicado: (2015) -
Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease
por: Belle, Ludovic, et al.
Publicado: (2016) -
Cutaneous Chronic Graft Versus Host Disease in a Symmetric Distribution
por: Shah, Nehal R, et al.
Publicado: (2019) -
Donor Treg expansion by liposomal α‐galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft‐versus‐host disease
por: Sugiura, Hiroyuki, et al.
Publicado: (2021)